Adherence to depression treatment in primary care a randomized clinical trial

Jo Anne Sirey, Samprit Banerjee, Patricia Marino, Martha L. Bruce, Ashley Halkett, Molly Turnwald, Claire Chiang, Brian Liles, Amanda Artis, Fred Blow, Helen C. Kales

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

IMPORTANCE Nonadherence to antidepressant medication is common and leads to poor outcomes. Early nonadherence is especially problematic. OBJECTIVE To test the effectiveness of a psychosocial intervention to improve early adherence among older patients whose primary care physician newly initiated an antidepressant for depression. DESIGN, SETTING, AND PARTICIPANTS The Treatment Initiation and Participation Program (TIP) was offered in a 2-site randomized clinical effectiveness study between January 2011 and December 2014 at primary care practices in New York, New York, and Ann Arbor, Michigan. Analyses began in February 2016. All participants were middle-aged and older adults (aged55 years) who received newly initiated depression treatment by their primary care physician and recruited within 10 days of their prescription. Analyses were intention-to-treat. INTERVENTIONS Participants were randomly assigned to the intervention (TIP) or treatment as usual. Participants in the TIP group identified and addressed barriers to adherence, including stigma, misconceptions, and fears about treatment, before developing a personalized adherence strategy. The Treatment Initiation and Participation Program was delivered in three 30-minute contacts scheduled during a 6-week period just after the antidepressant was prescribed. MAIN OUTCOMES AND MEASURES The primary outcomewas self-reported adherence on the Brief Medication Questionnaire, with adequate early adherence defined as taking 80% or more of the prescribed doses at 6 and 12 weeks. The secondary outcome was depression severity. RESULTS In total, 231 middle-aged and older adults (167 women [72.3%] and 64 men [27.7%]) without significant cognitive impairment were randomly assigned to the TIP intervention (n = 115) or treatment as usual (n = 116). Participants had a mean (SD) age of 67.3 (8.4) years. Participants in the TIP group were 5 times more likely to be adherent at 6 weeks (odds ratio, 5.54; 95%CI, 2.57 to 11.96x2 1 = 19.05; P < .001) and 3 times more likely to be adherent at both 6 and 12 weeks (odds ratio, 3.27; 95%CI, 1.73 to 6.17;x2 1 = 13.34; P < .001). Participants in the TIP group showed a significant earlier reduction (24.9%) in depressive symptoms (95%CI, 13.9 to 35.9; t337 = 4.46; adjusted P < .001). In both groups, participants who were 80% adherent at weeks 6 and 12 had a 15%greater improvement in depressive symptoms from baseline over the course of treatment (95%CI, .0.2 to .30; t369 = 1.93; P = .051).

Original languageEnglish (US)
Pages (from-to)1129-1135
Number of pages7
JournalJAMA Psychiatry
Volume74
Issue number11
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Primary Health Care
Randomized Controlled Trials
Depression
Antidepressive Agents
Primary Care Physicians
Therapeutics
Odds Ratio
Intention to Treat Analysis
Fear
Prescriptions

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Sirey, J. A., Banerjee, S., Marino, P., Bruce, M. L., Halkett, A., Turnwald, M., ... Kales, H. C. (2017). Adherence to depression treatment in primary care a randomized clinical trial. JAMA Psychiatry, 74(11), 1129-1135. https://doi.org/10.1001/jamapsychiatry.2017.3047

Adherence to depression treatment in primary care a randomized clinical trial. / Sirey, Jo Anne; Banerjee, Samprit; Marino, Patricia; Bruce, Martha L.; Halkett, Ashley; Turnwald, Molly; Chiang, Claire; Liles, Brian; Artis, Amanda; Blow, Fred; Kales, Helen C.

In: JAMA Psychiatry, Vol. 74, No. 11, 01.01.2017, p. 1129-1135.

Research output: Contribution to journalArticle

Sirey, JA, Banerjee, S, Marino, P, Bruce, ML, Halkett, A, Turnwald, M, Chiang, C, Liles, B, Artis, A, Blow, F & Kales, HC 2017, 'Adherence to depression treatment in primary care a randomized clinical trial', JAMA Psychiatry, vol. 74, no. 11, pp. 1129-1135. https://doi.org/10.1001/jamapsychiatry.2017.3047
Sirey JA, Banerjee S, Marino P, Bruce ML, Halkett A, Turnwald M et al. Adherence to depression treatment in primary care a randomized clinical trial. JAMA Psychiatry. 2017 Jan 1;74(11):1129-1135. https://doi.org/10.1001/jamapsychiatry.2017.3047
Sirey, Jo Anne ; Banerjee, Samprit ; Marino, Patricia ; Bruce, Martha L. ; Halkett, Ashley ; Turnwald, Molly ; Chiang, Claire ; Liles, Brian ; Artis, Amanda ; Blow, Fred ; Kales, Helen C. / Adherence to depression treatment in primary care a randomized clinical trial. In: JAMA Psychiatry. 2017 ; Vol. 74, No. 11. pp. 1129-1135.
@article{9e0449ed7cec437d898d05b992f32c88,
title = "Adherence to depression treatment in primary care a randomized clinical trial",
abstract = "IMPORTANCE Nonadherence to antidepressant medication is common and leads to poor outcomes. Early nonadherence is especially problematic. OBJECTIVE To test the effectiveness of a psychosocial intervention to improve early adherence among older patients whose primary care physician newly initiated an antidepressant for depression. DESIGN, SETTING, AND PARTICIPANTS The Treatment Initiation and Participation Program (TIP) was offered in a 2-site randomized clinical effectiveness study between January 2011 and December 2014 at primary care practices in New York, New York, and Ann Arbor, Michigan. Analyses began in February 2016. All participants were middle-aged and older adults (aged55 years) who received newly initiated depression treatment by their primary care physician and recruited within 10 days of their prescription. Analyses were intention-to-treat. INTERVENTIONS Participants were randomly assigned to the intervention (TIP) or treatment as usual. Participants in the TIP group identified and addressed barriers to adherence, including stigma, misconceptions, and fears about treatment, before developing a personalized adherence strategy. The Treatment Initiation and Participation Program was delivered in three 30-minute contacts scheduled during a 6-week period just after the antidepressant was prescribed. MAIN OUTCOMES AND MEASURES The primary outcomewas self-reported adherence on the Brief Medication Questionnaire, with adequate early adherence defined as taking 80{\%} or more of the prescribed doses at 6 and 12 weeks. The secondary outcome was depression severity. RESULTS In total, 231 middle-aged and older adults (167 women [72.3{\%}] and 64 men [27.7{\%}]) without significant cognitive impairment were randomly assigned to the TIP intervention (n = 115) or treatment as usual (n = 116). Participants had a mean (SD) age of 67.3 (8.4) years. Participants in the TIP group were 5 times more likely to be adherent at 6 weeks (odds ratio, 5.54; 95{\%}CI, 2.57 to 11.96x2 1 = 19.05; P < .001) and 3 times more likely to be adherent at both 6 and 12 weeks (odds ratio, 3.27; 95{\%}CI, 1.73 to 6.17;x2 1 = 13.34; P < .001). Participants in the TIP group showed a significant earlier reduction (24.9{\%}) in depressive symptoms (95{\%}CI, 13.9 to 35.9; t337 = 4.46; adjusted P < .001). In both groups, participants who were 80{\%} adherent at weeks 6 and 12 had a 15{\%}greater improvement in depressive symptoms from baseline over the course of treatment (95{\%}CI, .0.2 to .30; t369 = 1.93; P = .051).",
author = "Sirey, {Jo Anne} and Samprit Banerjee and Patricia Marino and Bruce, {Martha L.} and Ashley Halkett and Molly Turnwald and Claire Chiang and Brian Liles and Amanda Artis and Fred Blow and Kales, {Helen C.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1001/jamapsychiatry.2017.3047",
language = "English (US)",
volume = "74",
pages = "1129--1135",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Adherence to depression treatment in primary care a randomized clinical trial

AU - Sirey, Jo Anne

AU - Banerjee, Samprit

AU - Marino, Patricia

AU - Bruce, Martha L.

AU - Halkett, Ashley

AU - Turnwald, Molly

AU - Chiang, Claire

AU - Liles, Brian

AU - Artis, Amanda

AU - Blow, Fred

AU - Kales, Helen C.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - IMPORTANCE Nonadherence to antidepressant medication is common and leads to poor outcomes. Early nonadherence is especially problematic. OBJECTIVE To test the effectiveness of a psychosocial intervention to improve early adherence among older patients whose primary care physician newly initiated an antidepressant for depression. DESIGN, SETTING, AND PARTICIPANTS The Treatment Initiation and Participation Program (TIP) was offered in a 2-site randomized clinical effectiveness study between January 2011 and December 2014 at primary care practices in New York, New York, and Ann Arbor, Michigan. Analyses began in February 2016. All participants were middle-aged and older adults (aged55 years) who received newly initiated depression treatment by their primary care physician and recruited within 10 days of their prescription. Analyses were intention-to-treat. INTERVENTIONS Participants were randomly assigned to the intervention (TIP) or treatment as usual. Participants in the TIP group identified and addressed barriers to adherence, including stigma, misconceptions, and fears about treatment, before developing a personalized adherence strategy. The Treatment Initiation and Participation Program was delivered in three 30-minute contacts scheduled during a 6-week period just after the antidepressant was prescribed. MAIN OUTCOMES AND MEASURES The primary outcomewas self-reported adherence on the Brief Medication Questionnaire, with adequate early adherence defined as taking 80% or more of the prescribed doses at 6 and 12 weeks. The secondary outcome was depression severity. RESULTS In total, 231 middle-aged and older adults (167 women [72.3%] and 64 men [27.7%]) without significant cognitive impairment were randomly assigned to the TIP intervention (n = 115) or treatment as usual (n = 116). Participants had a mean (SD) age of 67.3 (8.4) years. Participants in the TIP group were 5 times more likely to be adherent at 6 weeks (odds ratio, 5.54; 95%CI, 2.57 to 11.96x2 1 = 19.05; P < .001) and 3 times more likely to be adherent at both 6 and 12 weeks (odds ratio, 3.27; 95%CI, 1.73 to 6.17;x2 1 = 13.34; P < .001). Participants in the TIP group showed a significant earlier reduction (24.9%) in depressive symptoms (95%CI, 13.9 to 35.9; t337 = 4.46; adjusted P < .001). In both groups, participants who were 80% adherent at weeks 6 and 12 had a 15%greater improvement in depressive symptoms from baseline over the course of treatment (95%CI, .0.2 to .30; t369 = 1.93; P = .051).

AB - IMPORTANCE Nonadherence to antidepressant medication is common and leads to poor outcomes. Early nonadherence is especially problematic. OBJECTIVE To test the effectiveness of a psychosocial intervention to improve early adherence among older patients whose primary care physician newly initiated an antidepressant for depression. DESIGN, SETTING, AND PARTICIPANTS The Treatment Initiation and Participation Program (TIP) was offered in a 2-site randomized clinical effectiveness study between January 2011 and December 2014 at primary care practices in New York, New York, and Ann Arbor, Michigan. Analyses began in February 2016. All participants were middle-aged and older adults (aged55 years) who received newly initiated depression treatment by their primary care physician and recruited within 10 days of their prescription. Analyses were intention-to-treat. INTERVENTIONS Participants were randomly assigned to the intervention (TIP) or treatment as usual. Participants in the TIP group identified and addressed barriers to adherence, including stigma, misconceptions, and fears about treatment, before developing a personalized adherence strategy. The Treatment Initiation and Participation Program was delivered in three 30-minute contacts scheduled during a 6-week period just after the antidepressant was prescribed. MAIN OUTCOMES AND MEASURES The primary outcomewas self-reported adherence on the Brief Medication Questionnaire, with adequate early adherence defined as taking 80% or more of the prescribed doses at 6 and 12 weeks. The secondary outcome was depression severity. RESULTS In total, 231 middle-aged and older adults (167 women [72.3%] and 64 men [27.7%]) without significant cognitive impairment were randomly assigned to the TIP intervention (n = 115) or treatment as usual (n = 116). Participants had a mean (SD) age of 67.3 (8.4) years. Participants in the TIP group were 5 times more likely to be adherent at 6 weeks (odds ratio, 5.54; 95%CI, 2.57 to 11.96x2 1 = 19.05; P < .001) and 3 times more likely to be adherent at both 6 and 12 weeks (odds ratio, 3.27; 95%CI, 1.73 to 6.17;x2 1 = 13.34; P < .001). Participants in the TIP group showed a significant earlier reduction (24.9%) in depressive symptoms (95%CI, 13.9 to 35.9; t337 = 4.46; adjusted P < .001). In both groups, participants who were 80% adherent at weeks 6 and 12 had a 15%greater improvement in depressive symptoms from baseline over the course of treatment (95%CI, .0.2 to .30; t369 = 1.93; P = .051).

UR - http://www.scopus.com/inward/record.url?scp=85033551458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033551458&partnerID=8YFLogxK

U2 - 10.1001/jamapsychiatry.2017.3047

DO - 10.1001/jamapsychiatry.2017.3047

M3 - Article

C2 - 28973066

AN - SCOPUS:85033551458

VL - 74

SP - 1129

EP - 1135

JO - JAMA Psychiatry

JF - JAMA Psychiatry

SN - 2168-622X

IS - 11

ER -